e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
382.87
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
380.26 (80)
Ask (Size)
383.00 (80)
Prev. Close
382.87
Today's Range
382.87 - 382.87
52wk Range
261.43 - 385.12
Shares Outstanding
538,800,000
Dividend Yield
2.49%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
Today 10:18 EST
As of February 27, 2026, the narrative surrounding Novo Nordisk (NYSE: NVO) has undergone a dramatic transformation. For the better part of three years, the Danish pharmaceutical giant was the...
Via
Finterra
Topics
Economy
Intellectual Property
Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial
February 23, 2026
The undisputed reign of Novo Nordisk in the weight-loss drug sector faced its most severe challenge to date on February 23, 2026, as the company’s US-traded shares (NYSE: NVO) plummeted 15.1% in a...
Via
MarketMinute
Performance
YTD
+16.9%
+16.9%
1 Month
+9.5%
+9.5%
3 Month
+12.2%
+12.2%
6 Month
+32.2%
+32.2%
1 Year
+23.6%
+23.6%
More News
Read More
Eli Lilly Surges as Novo Nordisk’s "CagriSema" Stumbles in High-Stakes Obesity Head-to-Head
February 23, 2026
Via
MarketMinute
Amgen CEO Teases 2026 As ‘Springboard Year’ After 14 Blockbusters And 18 Record Products
↗
February 04, 2026
Via
Stocktwits
Amgen Inc (NASDAQ:AMGN) Beats Q4 2025 Estimates and Provides Strong 2026 Revenue Guidance
↗
February 03, 2026
Via
Chartmill
Novo Nordisk Shares Plunge 13% as Next-Gen Weight Loss Drug CagriSema Fails to Topple Eli Lilly in Landmark Trial
February 23, 2026
Via
MarketMinute
Topics
Earnings
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
February 22, 2026
Via
StockStory
1 Momentum Stock to Research Further and 2 We Avoid
February 18, 2026
Via
StockStory
The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
February 17, 2026
Via
MarketMinute
Topics
Earnings
Economy
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Government
1 Large-Cap Stock Worth Your Attention and 2 We Avoid
February 12, 2026
Via
StockStory
The 5 Most Interesting Analyst Questions From Amgen’s Q4 Earnings Call
February 10, 2026
Via
StockStory
Topics
Earnings
The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
February 05, 2026
Via
MarketMinute
Topics
Earnings
Economy
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports
↗
February 05, 2026
Via
Stocktwits
Topics
Economy
Government
World Trade
Healthcare Titans Propel Dow to Record Highs as GLP-1 Sales Spark Major Market Rotation
February 05, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Intellectual Property
These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys?
↗
February 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
The $1 Trillion Apothecary: A Deep-Dive Research Report on Eli Lilly (LLY)
February 05, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
Why Is Amgen Stock Falling Premarket?
↗
February 05, 2026
Via
Stocktwits
Explore the top gainers and losers within the S&P500 index in today's session.
↗
February 04, 2026
Via
Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
↗
February 04, 2026
Via
Chartmill
AMGN Q4 Deep Dive: Product Portfolio Expansion and Pipeline Progress Drive Outlook
February 04, 2026
Via
StockStory
Amgen (AMGN) Q4 2025 Earnings Call Transcript
↗
February 03, 2026
Via
The Motley Fool
Topics
Earnings
Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025
February 03, 2026
Via
StockStory
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
February 02, 2026
Via
MarketMinute
Topics
ETFs
Government
Initial Public Offering
Amgen (AMGN) Reports Q4: Everything You Need To Know Ahead Of Earnings
February 01, 2026
Via
StockStory
Topics
Artificial Intelligence
Frequently Asked Questions
Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 382.87
When was Amgen last traded?
The last trade of Amgen was at 02/24/26 04:00 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 206.29B
How many shares of Amgen are outstanding?
Amgen has 206B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert